Genetic studies and TYK2 deficient mouse models have indicated JAK/STAT signaling pathway to participate in the pathogenesis of psoriasis and PsA via activation of the IL-23/IL-17 axis and induction of keratinocytes (Kcs) and gamma–delta T cells proliferation. This evidence concerns the gene SOAT1 and psoriasis.